Viewing StudyNCT00943540



Ignite Creation Date: 2024-05-05 @ 9:42 PM
Last Modification Date: 2024-10-26 @ 10:08 AM
Study NCT ID: NCT00943540
Status: COMPLETED
Last Update Posted: 2020-11-12
First Post: 2009-07-21

Brief Title: Pharmacokinetic and Safety Study of Raltegravir and Atazanavir in a Once Daily Dose Regimen in HIV-1 Infected Patients
Sponsor: Radboud University Medical Center
Organization: Radboud University Medical Center

Conditions & Keywords Data

Conditions:
Name
HIV Infections
HIV Infection
Keywords:
Name View
Treatment experienced View
pharmacokinetics View
single dose View
raltegravir View